Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Cilloni

Showing results (31-40 of 193) with videos related to

Pageof 20
Sort By:
Expert Review of Hematology|November 19, 2010
New mechanisms of resistance in Philadelphia chromosome acute lymphoblastic leukemiaGiovanni Martinelli, Ilaria Iacobucci, Simona Soverini, et al.
Neurology and Therapy|June 18, 2020
Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing-Remitting Multiple Sclerosis PatientsAntonio Bertolotto, Serena Martire, Luca Mirabile, et al.
Hematological Oncology|September 22, 2006
Monitoring minimal residual disease and controlling drug resistance in chronic myeloid leukaemia patients in treatment with imatinib as a guide to clinical managementGiovanni Martinelli, Ilaria Iacobucci, Simona Soverini, et al.
International Journal of Molecular Sciences|May 10, 2019
Digital PCR in Myeloid Malignancies: Ready to Replace Quantitative PCR?Daniela Cilloni, Jessica Petiti, Valentina Rosso, et al.
International Journal of Molecular Sciences|June 4, 2020
Mitochondria: A Galaxy in the Hematopoietic and Leukemic Stem Cell UniverseCristina Panuzzo, Aleksandar Jovanovski, Barbara Pergolizzi, et al.
Cancers|November 11, 2020
Standardization of BCR-ABL1 p210 Monitoring: From Nested to Digital PCRAleksandar Jovanovski, Jessica Petiti, Emilia Giugliano, et al.
Journal of Clinical Medicine|March 20, 2020
Landscape of Tumor Suppressor Mutations in Acute Myeloid LeukemiaCristina Panuzzo, Elisabetta Signorino, Chiara Calabrese, et al.
Annals of the New York Academy of Sciences|July 4, 2002
From genes to therapy: the case of Philadelphia chromosome-positive leukemiasDaniela Cilloni, Aagelo Guerrasio, Emilia Giugliano, et al.
Journal of Clinical Medicine|January 21, 2022
The Downregulation of Both Giant HERCs, <i>HERC1</i> and <i>HERC2</i>, Is an Unambiguous Feature of Chronic Myeloid Leukemia, and HERC1 Levels Are Associated with Leukemic Cell DifferentiationMuhammad Shahzad Ali, Stefano Magnati, Cristina Panuzzo, et al.
Blood|July 2, 2003
Usefulness of quantitative assessment of the WT1 gene transcript as a marker for minimal residual disease detectionDaniela Cilloni, Enrico Gottardi, Milena Fava, et al.
Pageof 20

Showing results (31-40 of 193) with videos related to

Sort By:
Pageof 20
Expert Review of Hematology|November 19, 2010
New mechanisms of resistance in Philadelphia chromosome acute lymphoblastic leukemiaGiovanni Martinelli, Ilaria Iacobucci, Simona Soverini, et al.
Neurology and Therapy|June 18, 2020
Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing-Remitting Multiple Sclerosis PatientsAntonio Bertolotto, Serena Martire, Luca Mirabile, et al.
Hematological Oncology|September 22, 2006
Monitoring minimal residual disease and controlling drug resistance in chronic myeloid leukaemia patients in treatment with imatinib as a guide to clinical managementGiovanni Martinelli, Ilaria Iacobucci, Simona Soverini, et al.
International Journal of Molecular Sciences|May 10, 2019
Digital PCR in Myeloid Malignancies: Ready to Replace Quantitative PCR?Daniela Cilloni, Jessica Petiti, Valentina Rosso, et al.
International Journal of Molecular Sciences|June 4, 2020
Mitochondria: A Galaxy in the Hematopoietic and Leukemic Stem Cell UniverseCristina Panuzzo, Aleksandar Jovanovski, Barbara Pergolizzi, et al.
Cancers|November 11, 2020
Standardization of BCR-ABL1 p210 Monitoring: From Nested to Digital PCRAleksandar Jovanovski, Jessica Petiti, Emilia Giugliano, et al.
Journal of Clinical Medicine|March 20, 2020
Landscape of Tumor Suppressor Mutations in Acute Myeloid LeukemiaCristina Panuzzo, Elisabetta Signorino, Chiara Calabrese, et al.
Annals of the New York Academy of Sciences|July 4, 2002
From genes to therapy: the case of Philadelphia chromosome-positive leukemiasDaniela Cilloni, Aagelo Guerrasio, Emilia Giugliano, et al.
Journal of Clinical Medicine|January 21, 2022
The Downregulation of Both Giant HERCs, <i>HERC1</i> and <i>HERC2</i>, Is an Unambiguous Feature of Chronic Myeloid Leukemia, and HERC1 Levels Are Associated with Leukemic Cell DifferentiationMuhammad Shahzad Ali, Stefano Magnati, Cristina Panuzzo, et al.
Blood|July 2, 2003
Usefulness of quantitative assessment of the WT1 gene transcript as a marker for minimal residual disease detectionDaniela Cilloni, Enrico Gottardi, Milena Fava, et al.
Pageof 20